Yu Mei

1.6k total citations
26 papers, 921 citations indexed

About

Yu Mei is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Yu Mei has authored 26 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 9 papers in Molecular Biology and 9 papers in Hepatology. Recurrent topics in Yu Mei's work include Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (9 papers) and Glioma Diagnosis and Treatment (7 papers). Yu Mei is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (9 papers) and Glioma Diagnosis and Treatment (7 papers). Yu Mei collaborates with scholars based in United States, Saudi Arabia and China. Yu Mei's co-authors include Wenya Linda Bi, Ian F. Dunn, Gavin P. Dunn, Rameen Beroukhim, Noah F. Greenwald, Sandro Santagata, Guofeng Cheng, William E. Delaney, Malak Abedalthagafi and Nathalie Y.R. Agar and has published in prestigious journals such as Circulation, Gastroenterology and PLoS ONE.

In The Last Decade

Yu Mei

25 papers receiving 907 citations

Peers

Yu Mei
Viera Nelson United States
Jae Yeon Seok South Korea
Jennifer Fischbach United States
Hong Bu China
D Batolo Italy
Sunita Badola United States
Yu Mei
Citations per year, relative to Yu Mei Yu Mei (= 1×) peers Giovanni Covini

Countries citing papers authored by Yu Mei

Since Specialization
Citations

This map shows the geographic impact of Yu Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Mei more than expected).

Fields of papers citing papers by Yu Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Mei. The network helps show where Yu Mei may publish in the future.

Co-authorship network of co-authors of Yu Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Mei. A scholar is included among the top collaborators of Yu Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Mei. Yu Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shin, Narae, Yu Mei, Xiaobo Tan, Vaibhav Srivastava, & Rajiv Ranganathan. (2025). Error compensation in a redundant system during ‘failure’ of individual motor elements. Experimental Brain Research. 243(2). 46–46.
2.
Allweiss, Lena, Barbara Testoni, Yu Mei, et al.. (2023). Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure. Gut. 72(5). 972–983. 43 indexed citations
3.
Lake, April D., Joseph C. Arezzo, Ricardo Ramírez, et al.. (2022). Neurotoxicity of an Hepatitis B Virus (HBV) Transcript Inhibitor in 13-Week Rat and Monkey Studies. Toxicological Sciences. 186(2). 298–308. 8 indexed citations
4.
Mei, Yu, Wenya Linda Bi, Changchen Hu, et al.. (2021). Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression. Pituitary. 24(3). 359–373. 18 indexed citations
5.
Ramírez, Ricardo, Nicholas van Buuren, Cameron M. Soulette, et al.. (2021). Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines. Journal of Virology. 95(19). e0029921–e0029921. 30 indexed citations
6.
Dvory‐Sobol, Hadas, Bin Han, Yu Mei, et al.. (2019). In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6. Journal of Viral Hepatitis. 26(8). 991–1001. 11 indexed citations
7.
Bi, Wenya Linda, Yu Mei, Malak Abedalthagafi, & Ian Dunn. (2018). Immune Microenvironment of Vestibular Schwannomas. Journal of Neurological Surgery Part B Skull Base. 79(S 01). S1–S188. 3 indexed citations
8.
Camus, Grégory, Simin Xu, Bin Han, et al.. (2017). Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems. Virology. 514. 134–141. 11 indexed citations
9.
Bi, Wenya Linda, Noah F. Greenwald, Shakti Ramkissoon, et al.. (2017). Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors. Endocrinology. 158(7). 2284–2291. 42 indexed citations
10.
Mei, Yu, Wenya Linda Bi, Noah F. Greenwald, et al.. (2017). Genomic profile of human meningioma cell lines. PLoS ONE. 12(5). e0178322–e0178322. 46 indexed citations
11.
Niu, Congrong, Christine M. Livingston, Li Li, et al.. (2017). The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection. PLoS ONE. 12(1). e0169648–e0169648. 114 indexed citations
12.
Mei, Yu, Ziming Du, Changchen Hu, et al.. (2017). Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling. Cell Communication and Signaling. 15(1). 34–34. 32 indexed citations
13.
Bi, Wenya Linda, Peleg Horowitz, Noah F. Greenwald, et al.. (2016). Landscape of Genomic Alterations in Pituitary Adenomas. Clinical Cancer Research. 23(7). 1841–1851. 88 indexed citations
14.
Johanns, Tanner M., Yujie Fu, Dale K. Kobayashi, et al.. (2016). High incidence of TERT mutation in brain tumor cell lines. Brain Tumor Pathology. 33(3). 222–227. 26 indexed citations
15.
Bi, Wenya Linda, Malak Abedalthagafi, Peleg Horowitz, et al.. (2016). Genomic landscape of intracranial meningiomas. Journal of neurosurgery. 125(3). 525–535. 84 indexed citations
16.
Cheng, Guofeng, Tian Yang, Brian Doehle, et al.. (2016). In Vitro Antiviral Activity and Resistance Profile Characterization of the Hepatitis C Virus NS5A Inhibitor Ledipasvir. Antimicrobial Agents and Chemotherapy. 60(3). 1847–1853. 50 indexed citations
17.
Bi, Wenya Linda, Michael Zhang, Winona Wu, Yu Mei, & Ian F. Dunn. (2016). Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications. Frontiers in Surgery. 3. 40–40. 73 indexed citations
18.
Bi, Wenya Linda, Yu Mei, Pankaj K. Agarwalla, Rameen Beroukhim, & Ian F. Dunn. (2016). Genomic and Epigenomic Landscape in Meningioma. Neurosurgery Clinics of North America. 27(2). 167–179. 30 indexed citations
19.
Mei, Yu, Amoreena C. Corsa, Simin Xu, et al.. (2013). In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons. Antiviral Research. 100(2). 439–445. 17 indexed citations
20.
Peng, Betty, Yu Mei, Simin Xu, et al.. (2012). Development of Robust Hepatitis C Virus Genotype 4 Subgenomic Replicons. Gastroenterology. 144(1). 59–61.e6. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026